Provectus Logo

6th Symposium on Melanoma and Other Cutaneous Malignancies

The lead investigator for Provectus' Phase 2 study of PV-10 for metastatic melanoma, Professor John F Thompson, MD, presented the update on Provectus' development efforts at The Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13, 2009 in New York City.

WMV Video download     Quicktime Video download